Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 7
1975 6
1976 3
1977 7
1978 5
1979 8
1980 12
1981 12
1982 21
1983 23
1984 11
1985 27
1986 21
1987 31
1988 26
1989 39
1990 43
1991 46
1992 55
1993 65
1994 51
1995 78
1996 89
1997 85
1998 134
1999 99
2000 86
2001 97
2002 93
2003 106
2004 86
2005 93
2006 83
2007 101
2008 83
2009 68
2010 72
2011 93
2012 96
2013 101
2014 99
2015 113
2016 92
2017 79
2018 70
2019 78
2020 86
2021 98
2022 109
2023 97
2024 103
2025 91
2026 16

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,206 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Low-dose or high-dose amoxicillin in vonoprazan-based dual therapy for Helicobacter pylori eradication? A systematic review and meta-analysis.
Ju KP, Kong QZ, Li YY, Li YQ. Ju KP, et al. Helicobacter. 2024 Jan-Feb;29(1):e13054. doi: 10.1111/hel.13054. Helicobacter. 2024. PMID: 38900537
BACKGROUND: The amoxicillin dose used in dual therapy to eradicate Helicobacter pylori varies across studies and the optimal amoxicillin dose for vonoprazan-based dual therapies remains unclear. We aimed to investigate the efficacy and safety of low- and high-dose …
BACKGROUND: The amoxicillin dose used in dual therapy to eradicate Helicobacter pylori varies across studies and the optimal amoxi …
PPI-amoxicillin dual therapy for Helicobacter pylori infection: An update based on a systematic review and meta-analysis.
Gao CP, Zhang D, Zhang T, Wang JX, Han SX, Graham DY, Lu H. Gao CP, et al. Helicobacter. 2020 Aug;25(4):e12692. doi: 10.1111/hel.12692. Epub 2020 Apr 20. Helicobacter. 2020. PMID: 32314468
We aimed to investigate whether PPI-amoxicillin dual therapy is effective. METHODS: We searched several publication databases for randomized controlled trials (RCTs) that compared PPI-amoxicillin dual therapy with controls up to March 2019. ...CONCLUSIONS: Compared …
We aimed to investigate whether PPI-amoxicillin dual therapy is effective. METHODS: We searched several publication databases for ran …
Vonoprazan-Amoxicillin Dual Therapy Versus Drug Sensitivity-Based Individualized Therapy as a Rescue Regimen for Helicobacter pylori Infection: A Multicenter, Randomized Controlled Trial.
Liu YX, Liu HN, Liu HQ, Yang YY, Cui HL, Fan LL, Sun WJ, Mei H, Wang XW, Yan G, Lan CH. Liu YX, et al. Helicobacter. 2025 Jan-Feb;30(1):e70009. doi: 10.1111/hel.70009. Helicobacter. 2025. PMID: 39996433 Clinical Trial.
Furthermore, the vonoprazan-amoxicillin dual therapy fulfilled the criteria for the non-inferiority test, when compared to individualized therapy. The incidence of adverse reactions was significantly lower in the vonoprazan-amoxicillin dual therapy group. Both group …
Furthermore, the vonoprazan-amoxicillin dual therapy fulfilled the criteria for the non-inferiority test, when compared to individual …
Vonoprazan-Amoxicillin Dual Therapy With Different Amoxicillin Administration Regimens for Helicobacter pylori Treatment: A Randomized Controlled Trial.
Qiu S, Huang Y, Chen J, Guo Y, Li M, Ding Z, Liang X, Lu H. Qiu S, et al. Helicobacter. 2024 Jul-Aug;29(4):e13118. doi: 10.1111/hel.13118. Helicobacter. 2024. PMID: 39087868 Clinical Trial.
BACKGROUND: The effect of preprandial or postprandial administration of amoxicillin on the efficacy of vonoprazan-amoxicillin dual therapy (VA-dual therapy) for Helicobacter pylori treatment has not been studied. It is also unclear whether amoxicillin dosing …
BACKGROUND: The effect of preprandial or postprandial administration of amoxicillin on the efficacy of vonoprazan-amoxicillin …
Amoxicillin or erythromycin for the treatment of antenatal chlamydial infection: a meta-analysis.
Turrentine MA, Newton ER. Turrentine MA, et al. Obstet Gynecol. 1995 Dec;86(6):1021-5. doi: 10.1016/0029-7844(95)00296-4. Obstet Gynecol. 1995. PMID: 7501326
The pooled RR for the effectiveness of amoxicillin compared with erythromycin was 1.11 (95% confidence interval [CI] 1.05-1.18), and the pooled RR for gastrointestinal side effects of amoxicillin compared with erythromycin was 0.29 (95% CI 0.20-0.42). The pooled RR …
The pooled RR for the effectiveness of amoxicillin compared with erythromycin was 1.11 (95% confidence interval [CI] 1.05-1.18), and …
Does the use of amoxicillin/amoxicillin-clavulanic acid in third molar surgery reduce the risk of postoperative infection? A systematic review with meta-analysis.
Menon RK, Gopinath D, Li KY, Leung YY, Botelho MG. Menon RK, et al. Int J Oral Maxillofac Surg. 2019 Feb;48(2):263-273. doi: 10.1016/j.ijom.2018.08.002. Epub 2018 Aug 23. Int J Oral Maxillofac Surg. 2019. PMID: 30145064
The objectives of this systematic review were to investigate the efficacy of amoxicillin/amoxicillin-clavulanic acid for reducing the risk of postoperative infection after third molar surgery and to evaluate the adverse outcomes in these patients, as well as in heal …
The objectives of this systematic review were to investigate the efficacy of amoxicillin/amoxicillin-clavulanic acid for reduc …
First-line Eradication of Helicobacter pylori Infection with High-Dose Amoxicillin and Vonoprazan: A Systematic Review and Meta-analysis.
Yu H, Zhou Z, Liu Z. Yu H, et al. Turk J Gastroenterol. 2025 Jun 16;36(7):410-419. doi: 10.5152/tjg.2025.24371. Turk J Gastroenterol. 2025. PMID: 40521782 Free PMC article.
There is a need to assess the high-dose amoxicillin (3 g/day) and vonoprazan dual therapy through meta-analysis to determine if it is more effective than previous protocols. ...CONCLUSION: The eradication rate of high-dose amoxicillin and vonoprazan dual regimen is …
There is a need to assess the high-dose amoxicillin (3 g/day) and vonoprazan dual therapy through meta-analysis to determine if it is …
Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Todd PA, Benfield P. Todd PA, et al. Drugs. 1990 Feb;39(2):264-307. doi: 10.2165/00003495-199039020-00008. Drugs. 1990. PMID: 2184003 Review.
Clavulanic acid enhances the antibacterial spectrum of amoxicillin by rendering most beta-lactamase-producing isolates susceptible to the drug. ...Thus, in general practice environments where beta-lactamase production has restricted the effectiveness of amoxicillin, …
Clavulanic acid enhances the antibacterial spectrum of amoxicillin by rendering most beta-lactamase-producing isolates susceptible to …
Randomized Trial of Amoxicillin for Pneumonia in Pakistan.
Jehan F, Nisar I, Kerai S, Balouch B, Brown N, Rahman N, Rizvi A, Shafiq Y, Zaidi AKM. Jehan F, et al. N Engl J Med. 2020 Jul 2;383(1):24-34. doi: 10.1056/NEJMoa1911998. N Engl J Med. 2020. PMID: 32609980 Free PMC article. Clinical Trial.
BACKGROUND: The World Health Organization (WHO) recommends oral amoxicillin for patients who have pneumonia with tachypnea, yet trial data indicate that not using amoxicillin to treat this condition may be noninferior to using amoxicillin. ...The primary outc …
BACKGROUND: The World Health Organization (WHO) recommends oral amoxicillin for patients who have pneumonia with tachypnea, yet trial …
3,206 results